BUFFALO, N.Y. — It is Alzheimer's Awareness Month, and it's a diseasearound one in nine people 65 and older in the United ...
Two major clinical trials evaluating the potential of the weight-loss drug semaglutide to treat Alzheimer’s disease have ...
Alzheimer's patients have been dealt a blow after disappointing results from a major trial. Novo Nordisk has announced that ...
A devoted son built a complicated technological apparatus to help his mother with dementia stay at home. It may have worked ...
Chris Hemsworth used "supersized" reminiscence therapy with his father, Craig, who has early-stage Alzheimer's, during a ...
New data raise the question of whether statins increase cardiovascular or cerebrovascular hospitalizations in dementia, but ...
Novo Nordisk's closely watched Alzheimer's trials of an older oral version of its semaglutide drug failed to help slow the ...
An older oral version of the company's semaglutide drug failed to meet its main goal in late-stage trials testing whether the ...
A Baker County family is demanding answers after they say they were told their loved one with Dementia was attacked by a ...
The results from the two trials of early-stage Alzheimer's patients, called EVOKE and EVOKE+, are another setback for the ...
Novo Nordisk said on Monday an older oral version of its semaglutide drug failed to meet its main goal in late-stage trials ...
Johnson & Johnson ends its Phase 2b posdinemab trial after missing key Alzheimer's goals, raising concerns for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results